Search Results - "AHUJA, H. G"
-
1
Phase II study of arsenic trioxide and ascorbic acid for relapsed or refractory lymphoid malignancies: a Wisconsin Oncology Network study
Published in Hematological oncology (01-03-2009)“…Arsenic trioxide (As2O3) has established clinical activity in acute promyelocytic leukaemia and has pre‐clinical data suggesting activity in lymphoid…”
Get full text
Journal Article -
2
Abnormalities of the retinoblastoma gene in the pathogenesis of acute leukemia
Published in Blood (15-12-1991)“…The retinoblastoma-susceptibility (Rb) gene is an antioncogene that is frequently altered in retinoblastomas, sarcomas, and some epithelial tumors. We examined…”
Get full text
Journal Article -
3
The Pattern of Mutational Involvement of RAS Genes in Human Hematologic Malignancies Determined by DNA Amplification and Direct Sequencing
Published in Blood (15-04-1990)“…DNA from 161 patients with various forms of hematologic malignancies were investigated for mutations in exons 1 and 2 of the N-RAS. K-RAS and Ha-RAS gene by…”
Get full text
Journal Article -
4
Correlation Between Molecular and Clinical Events in the Evolution of Chronic Myelocytic Leukemia to Blast Crisis
Published in Blood (01-06-1991)“…A patient with typical Philadelphia chromosome (Ph1)-positive chronic myelocytic leukemia (CML) was studied during sequential phases of disease: (1) initial…”
Get full text
Journal Article -
5
The t(11;20)(p15;q11) chromosomal translocation associated with therapy-related myelodysplastic syndrome results in an NUP98-TOP1 fusion
Published in Blood (01-11-1999)“…The NUP98 gene is involved in 3 distinct chromosomal rearrangements, t(7;11)(p15;p15), t(2;11)(q31;p15), and inv(11)(p15q22); all of these NUP98 rearrangements…”
Get full text
Journal Article -
6
A splicing mutation accounts for the lack of p53 gene expression in a CML blast crisis cell line: a novel mechanism of p53 gene inactivation
Published in British journal of haematology (01-09-1990)“…Alterations of the p53 anti-oncogene have recently been found to occur frequently in the blast crisis of chronic myelocytic leukaemia. The p53 gene may be…”
Get more information
Journal Article -
7
t(9;11)(p22;p15) in acute myeloid leukemia results in a fusion between NUP98 and the gene encoding transcriptional coactivators p52 and p75-lens epithelium-derived growth factor (LEDGF)
Published in Cancer research (Chicago, Ill.) (15-11-2000)“…A t(9;11)(p22;p15) chromosomal translocation was identified in an adult patient with de novo acute myelogenous leukemia. Fluorescence in situ hybridization and…”
Get full text
Journal Article -
8
NUP98 gene rearrangements and the clonal evolution of chronic myelogenous leukemia
Published in Genes chromosomes & cancer (01-04-2001)“…The role of the BCR‐ABL fusion gene in the pathogenesis of the chronic phase of chronic myelogenous leukemia (CML) has been well established. Several…”
Get full text
Journal Article -
9
Variation in the protein coding region of the human p53 gene
Published in Oncogene (01-09-1990)“…This report describes a restriction fragment length polymorphism for the enzyme BglII caused by a conserved C to T change at residue 21 of the human p53 gene…”
Get more information
Journal Article -
10
Analysis of Proto-Oncogenes in Acute Myeloid Leukemia: Loss of Heterozygosity for the Ha-ras Gene
Published in Blood (15-02-1990)“…At least 13 of 34 patients with acute myeloid leukemia (AML) of varying FAB types were heterozygous for a BamHI restriction fragment length polymorphism (RFLP)…”
Get full text
Journal Article -
11
Potential role for DNA topoisomerase II poisons in the generation of t(11;20)(p15;q11) translocations
Published in Genes chromosomes & cancer (01-10-2000)“…Chromosomal aberrations are frequently associated with therapy‐related myelodysplastic syndromes and acute myelogenous leukemia (t‐MDS/AML) and are thought to…”
Get full text
Journal Article -
12
Vorinostat (V) and bortezomib (B) as third-line treatment in patients with advanced non-small cell lung cancer (NSCLC): A Wisconsin Oncology Network Phase II Study
Published in Journal of clinical oncology (20-05-2011)“…Abstract only…”
Get full text
Journal Article -
13
A phase II consortium trial of vorinostat and bortezomib for advanced soft tissue sarcomas
Published in Journal of clinical oncology (20-05-2011)“…Abstract only…”
Get full text
Journal Article -
14
Clinical and phenotypic heterogeneity in L3-acute lymphoblastic leukaemia
Published in Indian journal of cancer (01-06-1988)Get more information
Journal Article -
15
Pre-sepsis prophylaxis and empirical treatment of febrile patients with neutropenia in acute leukaemia
Published in Journal of the Association of Physicians of India (01-08-1986)Get more information
Journal Article -
16
Hairy cell leukaemia: a clinicopathological study
Published in Journal of the Association of Physicians of India (01-10-1986)Get more information
Journal Article -
17
Outcome of aggressive induction therapy in acute non-lymphocytic leukaemia
Published in Journal of the Association of Physicians of India (01-03-1985)Get more information
Journal Article -
18
T-cell chronic lymphocytic leukaemia
Published in Indian journal of cancer (01-09-1988)Get more information
Journal Article -
19
Phase I/II study of exisulind and gemcitabine in patients with recurrent advanced non-small cell lung cancer (NSCLC)
Published in Journal of clinical oncology (15-07-2004)“…Abstract only…”
Get full text
Journal Article -
20
Phase I/II study of exisulind and gemcitabine in patients with recurrent advanced non-small cell lung cancer (NSCLC)
Published in Journal of clinical oncology (15-07-2004)“…Abstract only…”
Get full text
Journal Article